News
Global and national biosimilars players increasing
2015-06-11 The number of players in the biosimilars field is increasing with both originator and generics manufacturers devoting resources to biosimilars. This applies to global companies… Read More »
European initiatives to enhance losartan utilization post generics: impact and implications
2015-06-09 Health authorities have the opportunity to realize considerable savings from generics. A wide variety of strategies were instigated across Europe to encourage prescribing of losartan… Read More »
Strategy for biosimilars in China
2015-06-05 China is one of the largest pharmaceutical markets in the world, and has seen rapid growth in the biopharmaceuticals industry in recent years. However, it… Read More »
The ethics of generic immunosuppressive drugs
2015-06-03 A literature review of generic immunosuppressive drugs (ISDs) in renal transplant patients concludes that it is ethical to prescribe generic ISDs provided regulatory safeguards are… Read More »
Biosimilars in emerging markets
2015-06-01 Less strict or ‘relaxed’ regulatory requirements for biosimilars in some emerging markets are driving the proliferation of non-originator biologicals [1]. Non-originator biologicals can be defined… Read More »
Patient access to rituximab in emerging markets
2015-05-28 A Pfizer-sponsored study looking at access to the oncology treatment rituximab has revealed that use of this important drug would increase across all therapy types… Read More »
Concerns from EU and US over Colombian biologicals guidelines
2015-05-26 On 21 January 2013, the Colombian Ministry of Health and Social Protection (Ministerio de Salud y Protección Social de Colombia) released a new draft guideline… Read More »
Generics group calls for say on ICH standards
2015-05-22 The generics industry is somewhat annoyed at being excluded from the decision-making process of a global organization, which harmonizes drug quality, safety and efficacy standards.… Read More »
Generic hepatitis drug to be made available to 80 countries
2015-05-20 Originator pharma company Gilead Sciences (Gilead) is reportedly close to reaching a deal with generics makers to bring low cost versions of its hepatitis C… Read More »
Pharma’s future in China and the US
2015-05-18 Although generics will increase their share of all prescriptions in China and the US over the next 10 years, economic and structural incentives for new… Read More »
